A- A A+

Chih-Ching Lin (林志慶)

Chih-Ching Lin(林志慶)


  1. 國立陽明大學醫學院醫學士
  2. 國立陽明大學臨床醫學研究所博士
經歷 現職:
  1. - 迄今 臺北榮民總醫內科部腎臟科主任(2021/06)
  2. - 迄今 臺北榮民總醫院國際醫療中心主任
  3. - 迄今 臺北榮民總醫院內科部腎臟科主治醫師
  1. - 國立陽明大學醫學院醫學系內科學科專任教授
  1. 腎臟衰竭
  2. 尿液異常
  3. 透析治療
  4. 透析血管通路功能失調
  1. 台灣醫師執照
  2. 台灣內科學會專科醫師執照
  3. 台灣腎臟學會專科醫師執照
  1. 國語 台語 英語


1.    Chao-Fu Chang, Wu-Chang Yang, Chih-Ching Lin. Nephrogenic Syndrome of Inappropriate Antidiuresis. N Engl J Med 2005;353(5):529-30. SCI IF=55.873
2.    Chih-Ching Lin, Wu-Chang Yang, Shing-Jong Lin, Tzen-Wen Chen, Wen-Shin Lee, Chao-Fu Chang, Pui-Ching Lee,  Shou-Dong Lee, Ming-Yi Chung. Length Polymorphism in Heme Oxygenase-1 is Associated with Arteriovenous Fistula Patency in Hemodialysis Patients. Kidney Int 2006; 69:165–72. SCI IF =8.563
3.    Chih-Ching Lin, Chao-Fu Chang, Ming-Yu Lai, Tzen-Wen Chen, Pui-Ching Lee, Wu-Chang Yang. Far Infrared Therapy: a Novel Treatment Improving Access Blood Flow and Unassisted Patency of Arteriovenous Fistula in Hemodialysis Patients J Am Soc Nephrol 2007; 18: 985-92. SCI IF=9.343
4.    Chih-Ching Lin, Wu-Chang Yang, Min-Chi Chen, Wen-Sheng Liu, Chih-Yu Yang, Pui-Ching Lee. Effect of Far Infrared Therapy on Arteriovenous Fistula Maturation: An Open-Label Randomized Controlled Trial. Am J Kidney Dis 2013; 62 (2): 304-11 SCI IF=5.900
5.    Ou SM, Shih CJ, Chao PW, Chu H, Kuo SC, Lee YJ, Wang SJ, Yang CY, Lin CC, Chen TJ, Tarng DC, Li SY, Chen YT. Effects of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylureas as Add-On Therapy after Metformin on the Clinical Outcomes in Patients with Type 2 Diabetes. Annals of Internal Medicine 2015 ;163(9):663-72 SCI IF=17.81